Segment Information - Major Customers (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Loss Contingencies [Line Items] | ||||
| Revenues from external customers | $ 63,609 | $ 48,727 | $ 180,776 | $ 143,275 |
| Revenue | Customer Concentration Risk | Single Pharmacy Benefit Client | ||||
| Loss Contingencies [Line Items] | ||||
| Concentration percentage | 16.00% | 16.00% | ||
| Revenue | Customer Concentration Risk | U.S. Federal Government Agencies | ||||
| Loss Contingencies [Line Items] | ||||
| Concentration percentage | 10.00% | 11.00% | ||
| X | ||||||||||
- Definition Revenue excluding net investment income and realized investment results. No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|